Staphylococcus aureus toxins

Current Opinion in Microbiology

Volumn 17, Issue 1, 2014, Pages 32-37

  Otto, Michael ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM10 ENDOPEPTIDASE; BACTERIAL TOXIN; CALCINEURIN; COMPLEMENT COMPONENT C3B; DELTA HEMOLYSIN; INTERLEUKIN 1; INTERLEUKIN 2; LEUKOCIDIN AB; PANTON VALENTINE LEUKOCIDIN; STAPHYLOCOCCUS AUREUS TOXIN; STAPHYLOKINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UVOMORULIN; VON WILLEBRAND FACTOR;

ANTIGEN PRESENTING CELL; BACTERIAL CLEARANCE; CYTOKINE RELEASE; CYTOPLASM; ENZYME ACTIVATION; ERYTHROCYTE; HOST RESISTANCE; LEUKOCYTE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PHAGOSOME; PROTEIN CLEAVAGE; REVIEW; STAPHYLOCOCCUS AUREUS;

BACTERIAL TOXINS; HUMANS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84890105937     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2013.11.004     Document Type: Review

References (49)

1. Francis J.S., Doherty M.C., Lopatin U., Johnston C.P., Sinha G., Ross T., Cai M., Hansel N.N., Perl T., Ticehurst J.R., et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005, 40:100-107.
2. Miller L.G., Perdreau-Remington F., Rieg G., Mehdi S., Perlroth J., Bayer A.S., Tang A.W., Phung T.O., Spellberg B. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005, 352:1445-1453.
3. Morikawa K., Takemura A.J., Inose Y., Tsai M., Nguyen Thi le T., Ohta T., Msadek T. Expression of a cryptic secondary sigma factor gene unveils natural competence for DNA transformation in Staphylococcus aureus. PLoS Pathog 2012, 8:e1003003.
4. Heilmann C. Adhesion mechanisms of staphylococci. Adv Exp Med Biol 2011, 715:105-123.
5. Berube B.J., Bubeck Wardenburg J. Staphylococcus aureus alpha-toxin: nearly a century of intrigue. Toxins (Basel) 2013, 5:1140-1166.
6. Valeva A., Walev I., Pinkernell M., Walker B., Bayley H., Palmer M., Bhakdi S. Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. Proc Natl Acad Sci U S A 1997, 94:11607-11611.
7. Inoshima I., Inoshima N., Wilke G.A., Powers M.E., Frank K.M., Wang Y., Bubeck Wardenburg J. A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat Med 2011, 17:1310-1314.
8. Wilke G.A., Bubeck Wardenburg J. Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury. Proc Natl Acad Sci U S A 2010, 107:13473-13478.
9. Nygaard T.K., Pallister K.B., DuMont A.L., DeWald M., Watkins R.L., Pallister E.Q., Malone C., Griffith S., Horswill A.R., Torres V.J., et al. Alpha-toxin induces programmed cell death of human T cells, B cells, and monocytes during USA300 infection. PLoS ONE 2012, 7:e36532.
10. Vandenesch F., Naimi T., Enright M.C., Lina G., Nimmo G.R., Heffernan H., Liassine N., Bes M., Greenland T., Reverdy M.E., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003, 9:978-984.
11. Otto M. Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu Rev Microbiol 2010, 64:143-162.
12. Alonzo F., Kozhaya L., Rawlings S.A., Reyes-Robles T., DuMont A.L., Myszka D.G., Landau N.R., Unutmaz D., Torres V.J. CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature 2013, 493:51-55.
13. DuMont A.L., Yoong P., Day C.J., Alonzo F., 3rd, McDonald W.H., Jennings M.P., Torres V.J. Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1. Proc Natl Acad Sci U S A 2013, 110:10794-10799.
14. Spaan A.N., Henry T., van Rooijen W.J., Perret M., Badiou C., Aerts P.C., Kemmink J., de Haas C.J., van Kessel K.P., Vandenesch F., et al. The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors. Cell Host Microbe 2013, 13:584-594.
15. Loffler B., Hussain M., Grundmeier M., Bruck M., Holzinger D., Varga G., Roth J., Kahl B.C., Proctor R.A., Peters G. Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 2010, 6:e1000715.
16. Wang R., Braughton K.R., Kretschmer D., Bach T.H., Queck S.Y., Li M., Kennedy A.D., Dorward D.W., Klebanoff S.J., Peschel A., et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007, 13:1510-1514.
17. Rautenberg M., Joo H.S., Otto M., Peschel A. Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence. FASEB J 2011, 25:1254-1263.
18. Kretschmer D., Gleske A.K., Rautenberg M., Wang R., Koberle M., Bohn E., Schoneberg T., Rabiet M.J., Boulay F., Klebanoff S.J., et al. Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe 2010, 7:463-473.
19. Talbot J.C., Thiaudiere E., Vincent M., Gallay J., Siffert O., Dufourcq J. Dynamics and orientation of amphipathic peptides in solution and bound to membranes: a steady-state and time-resolved fluorescence study of staphylococcal delta-toxin and its synthetic analogues. Eur Biophys J 2001, 30:147-161.
20. Cheung G.Y., Kretschmer D., Queck S.Y., Joo H.S., Wang R., Duong A.C., Nguyen T.H., Bach T.H., Porter A.R., DeLeo F.R., et al. Insight into structure-function relationship in phenol-soluble modulins using an alanine screen of the phenol-soluble modulin (PSM) alpha3 peptide. FASEB J 2013, (in press): Epub.
21. Li M., Diep B.A., Villaruz A.E., Braughton K.R., Jiang X., DeLeo F.R., Chambers H.F., Lu Y., Otto M. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A 2009, 106:5883-5888.
22. Chatterjee S.S., Joo H.S., Duong A.C., Dieringer T.D., Tan V.Y., Song Y., Fischer E.R., Cheung G.Y.C., Li M., Otto M. Essential Staphylococcus aureus toxin export system. Nat Med 2013, 19:364-367.
23. Surewaard B., de Haas C., Vervoort F., Rigby K., Deleo F., Otto M., van Strijp J., Nijland R. Staphylococcal alpha-phenol soluble modulins contribute to neutrophil lysis after phagocytosis. Cell Microbiol 2013, 15:1427-1437.
24. Geiger T., Francois P., Liebeke M., Fraunholz M., Goerke C., Krismer B., Schrenzel J., Lalk M., Wolz C. The stringent response of Staphylococcus aureus and its impact on survival after phagocytosis through the induction of intracellular PSMs expression. PLoS Pathog 2012, 8:e1003016.
25. DeLeo F.R., Otto M. An antidote for Staphylococcus aureus pneumonia?. J Exp Med 2008, 205:271-274.
26. Ventura C.L., Malachowa N., Hammer C.H., Nardone G.A., Robinson M.A., Kobayashi S.D., DeLeo F.R. Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics. PLoS ONE 2010, 5:e11634.
27. DuMont A.L., Yoong P., Surewaard B.G., Benson M.A., Nijland R., van Strijp J.A., Torres V.J. Staphylococcus aureus elaborates leukocidin AB to mediate escape from within human neutrophils. Infect Immun 2013, 81:1830-1841.
28. Nakamura Y., Oscherwitz J., Cease K.B., Chan S.M., Munoz-Planillo R., Hasegawa M., Villaruz A.E., Cheung G.Y., McGavin M.J., Otto M., et al. Staphylococcus δ-toxin promotes allergic skin disease by inducing mast cell degranulation. Nature 2013, 503:397-401.
29. Hennekinne J.A., De Buyser M.L., Dragacci S. Staphylococcus aureus and its food poisoning toxins: characterization and outbreak investigation. FEMS Microbiol Rev 2012, 36:815-836.
30. Lin C.F., Chen C.L., Huang W.C., Cheng Y.L., Hsieh C.Y., Wang C.Y., Hong M.Y. Different types of cell death induced by enterotoxins. Toxins (Basel) 2010, 2:2158-2176.
31. Zapor M., Fishbain J.T. Aerosolized biologic toxins as agents of warfare and terrorism. Respir Care Clin N Am 2004, 10:111-122.
32. Salgado-Pabon W., Breshears L., Spaulding A.R., Merriman J.A., Stach C.S., Horswill A.R., Peterson M.L., Schlievert P.M. Superantigens are critical for Staphylococcus aureus infective endocarditis, sepsis, and acute kidney injury. mBio 2013, 4:e00494-13.
33. Wilson G.J., Seo K.S., Cartwright R.A., Connelley T., Chuang-Smith O.N., Merriman J.A., Guinane C.M., Park J.Y., Bohach G.A., Schlievert P.M., et al. A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia. PLoS Pathog 2011, 7:e1002271.
34. de Haas C.J., Veldkamp K.E., Peschel A., Weerkamp F., Van Wamel W.J., Heezius E.C., Poppelier M.J., Van Kessel K.P., van Strijp J.A. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 2004, 199:687-695.
35. Prat C., Haas P.J., Bestebroer J., de Haas C.J., van Strijp J.A., van Kessel K.P. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR. J Immunol 2009, 183:6569-6578.
36. Prat C., Bestebroer J., de Haas C.J., van Strijp J.A., van Kessel K.P. A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1. J Immunol 2006, 177:8017-8026.
37. Stemerding A.M., Kohl J., Pandey M.K., Kuipers A., Leusen J.H., Boross P., Nederend M., Vidarsson G., Weersink A.Y., van de Winkel J.G., et al. Staphylococcus aureus formyl peptide receptor-like 1 inhibitor (FLIPr) and its homologue FLIPr-like are potent FcgammaR antagonists that inhibit IgG-mediated effector functions. J Immunol 2013, 191:353-362.
38. Cassat J.E., Hammer N.D., Campbell J.P., Benson M.A., Perrien D.S., Mrak L.N., Smeltzer M.S., Torres V.J., Skaar E.P. A secreted bacterial protease tailors the Staphylococcus aureus virulence repertoire to modulate bone remodeling during osteomyelitis. Cell Host Microbe 2013, 13:759-772.
39. Jusko M., Potempa J., Kantyka T., Bielecka E., Miller H.K., Kalinska M., Dubin G., Garred P., Shaw L.N., Blom A.M. Staphylococcal proteases aid in evasion of the human complement system. J Innate Immun 2013, (in press): Epub.
40. Bukowski M., Wladyka B., Dubin G. Exfoliative toxins of Staphylococcus aureus. Toxins (Basel) 2010, 2:1148-1165.
41. Rooijakkers S.H., van Wamel W.J., Ruyken M., van Kessel K.P., van Strijp J.A. Anti-opsonic properties of staphylokinase. Microbes Infect 2005, 7:476-484.
42. Hammel M., Sfyroera G., Ricklin D., Magotti P., Lambris J.D., Geisbrecht B.V. A structural basis for complement inhibition by Staphylococcus aureus. Nat Immunol 2007, 8:430-437.
43. Jongerius I., Kohl J., Pandey M.K., Ruyken M., van Kessel K.P., van Strijp J.A., Rooijakkers S.H. Staphylococcal complement evasion by various convertase-blocking molecules. J Exp Med 2007, 204:2461-2471.
44. Kwiecinski J., Jacobsson G., Karlsson M., Zhu X., Wang W., Bremell T., Josefsson E., Jin T. Staphylokinase promotes the establishment of Staphylococcus aureus skin infections while decreasing disease severity. J Infect Dis 2013, 208:990-999.
45. Thomer L., Schneewind O., Missiakas D. Multiple ligands of von Willebrand factor binding protein (vWbp) promote Staphylococcus aureus clot formation in human plasma. J Biol Chem 2013, 288:28283-28292.
46. Cheng A.G., McAdow M., Kim H.K., Bae T., Missiakas D.M., Schneewind O. Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog 2010, 6:e1001036.
47. Vanassche T., Peetermans M., Van Aelst L.N., Peetermans W.E., Verhaegen J., Missiakas D.M., Schneewind O., Hoylaerts M.F., Verhamme P. The role of staphylothrombin-mediated fibrin deposition in catheter-related Staphylococcus aureus infections. J Infect Dis 2013, 208:92-100.
48. Novick R.P., Schlievert P., Ruzin A. Pathogenicity and resistance islands of staphylococci. Microbes Infect 2001, 3:585-594.
49. Brinkmann V., Zychlinsky A. Neutrophil extracellular traps: is immunity the second function of chromatin?. J Cell Biol 2012, 198:773-783.